RxNorm Semantic Concepts Index - 346
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "346".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 346021 | leuprolide 22.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346027 | sodium fluoride 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346032 | magnesium chloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346038 | cysteine 3.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346039 | inositol 8.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 34604 | prolintane | Full form of descriptor (FN) | NO | |
RxCUI: 34604 | prolintane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 34604 | prolintane | Designated preferred name (PT) | NO | |
RxCUI: 34604 | prolintane | Full form of descriptor (FN) | NO | |
RxCUI: 34604 | prolintane | Designated preferred name (PT) | NO | |
RxCUI: 346040 | methionine 8.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346041 | sodium propionate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346042 | urea 83.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346045 | dextran 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346057 | activated charcoal 25000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346058 | imiquimod 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 34608 | Prolyl-(D,L)-alanine-peptidyl hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 34608 | Prolyl-(D,L)-alanine-peptidyl hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 34608 | Prolyl-(D,L)-alanine-peptidyl hydrolase | Designated preferred name (PT) | NO | |
RxCUI: 34608 | Prolyl-(D,L)-alanine-peptidyl hydrolase | Full form of descriptor (FN) | NO | |
RxCUI: 34608 | Prolyl-(D,L)-alanine-peptidyl hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 34608 | Prolyl-(D,L)-alanine-peptidyl hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 34609 | Prolyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 34609 | Prolyl-tRNA synthetase | Full form of descriptor (FN) | NO | |
RxCUI: 34609 | Prolyl-tRNA synthetase | Designated preferred name (PT) | NO | |
RxCUI: 34609 | Prolyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346119 | atropine 0.06 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346120 | benzoic acid 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346121 | racepinephrine 22.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346122 | sodium hyaluronate 16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346124 | isopropyl alcohol 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346128 | cimetidine 3.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346130 | zinc undecylenate 0.12 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346131 | ammonium chloride 486 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346134 | chlorhexidine gluconate 1.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346135 | calcium chloride 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346136 | polyethylene glycols 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346137 | levalbuterol 0.21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346138 | levalbuterol 0.417 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346139 | Monascus purpureus West 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346141 | rofecoxib 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346142 | rofecoxib 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346143 | rofecoxib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346144 | rofecoxib 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346145 | gabapentin 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346146 | gabapentin 800 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346147 | doxercalciferol 0.002 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346148 | budesonide 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346149 | vitamin K1 0.04 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346154 | bitolterol 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346161 | Inhalation Solution | Dose Form (DF) | YES | |
RxCUI: 346162 | Spray | Dose Form (DF) | NO | |
RxCUI: 346163 | Mucosal Spray | Dose Form (DF) | YES | |
RxCUI: 346164 | Oral Spray | Dose Form (DF) | YES | |
RxCUI: 346165 | Topical Spray | Dose Form (DF) | YES | |
RxCUI: 346166 | Intramuscular Solution | Dose Form (DF) | NO | |
RxCUI: 346167 | Intramuscular Suspension | Dose Form (DF) | NO | |
RxCUI: 346168 | Intravenous Suspension | Dose Form (DF) | NO | |
RxCUI: 346169 | Oral Jelly | Dose Form (DF) | YES | |
RxCUI: 346169 | Oral Jelly | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 346170 | Rectal Jelly | Dose Form (DF) | YES | |
RxCUI: 346170 | Rectal Jelly | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 346171 | Oral Paste | Dose Form (DF) | YES | |
RxCUI: 346173 | methylPREDNISolone 62.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346173 | methylPREDNISolone 62.5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 346175 | Lopap brand of acetaminophen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 346180 | acetaminophen 2.89 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346183 | acetaminophen 3.61 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346186 | compound benzoin tincture (USP) 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346187 | bacitracin 4 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346188 | albuterol 0.83 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346190 | Arm-A-Med | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 346193 | alprostadil 0.04 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346197 | 6-aminocaproic acid 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346198 | 6-aminocaproic acid 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346199 | Tylenol Severe Allergy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 346200 | anistreplase 6 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346204 | ascorbic acid 500 MG Oral Tablet [Sunkist Vitamin C] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346204 | ascorbic acid 500 MG Oral Tablet [Sunkist Vitamin C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346204 | ascorbic acid 500 MG Oral Tablet [Sunkist Vitamin C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346204 | ascorbic acid 500 MG Oral Tablet [Sunkist Vitamin C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346209 | CARBOplatin 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346209 | CARBOplatin 10 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 346210 | Os-Cal 500 MG Oral Tablet, as calcium carbonate | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 346210 | Os-Cal 500 MG Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 346210 | Os-Cal 500 MG Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 346211 | Oysco 500 MG Oral Tablet, as calcium carbonate | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346211 | Oysco 500 MG Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346211 | Oysco 500 MG Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346213 | capsaicin 0.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346215 | ceFAZolin 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346215 | ceFAZolin 250 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 346216 | cefonicid 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346219 | cefTAZidime 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346219 | cefTAZidime 250 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 346223 | Cholestin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 346224 | flurandrenolide 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346225 | flurandrenolide 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346228 | pemoline 37.5 MG Oral Tablet [Cylert] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346228 | pemoline 37.5 MG Oral Tablet [Cylert] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346229 | lactase 3000 UNT Oral Tablet [Dairy Digest] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346229 | lactase 3000 UNT Oral Tablet [Dairy Digest] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346230 | benzoyl peroxide 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346234 | imipenem 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346235 | diperodon 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346240 | follicle stimulating hormone 150 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346241 | somatropin 0.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346242 | somatropin 1.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346243 | somatropin 2.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346244 | somatropin 3.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346245 | somatropin 4.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346246 | somatropin 5.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346247 | somatropin 6.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346248 | somatropin 7.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346249 | hexachlorophene 2.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 34625 | promestriene | Full form of descriptor (FN) | NO | |
RxCUI: 34625 | promestriene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 34625 | promestriene | Designated preferred name (PT) | NO | |
RxCUI: 34625 | promestriene | Full form of descriptor (FN) | NO | |
RxCUI: 34625 | promestriene | Designated preferred name (PT) | NO | |
RxCUI: 346250 | somatropin 3.33 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346254 | interferon alfa-2b 10000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346255 | interferon alfa-2b 15000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346257 | interferon alfa-2b 6000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346258 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Otic Ear Care] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346258 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Otic Ear Care] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346258 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Otic Ear Care] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346259 | Otimar 0.35 % / 10,000 UNT/ML / 1 % Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346259 | Otimar 0.35 % / 10,000 UNT/ML / 1 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346259 | Otimar 0.35 % / 10,000 UNT/ML / 1 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346259 | Otimar 0.35 % / 10,000 UNT/ML / 1 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346260 | theophylline 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346261 | isosorbide dinitrate 5 MG Chewable Tablet [Sorbitrate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346261 | isosorbide dinitrate 5 MG Chewable Tablet [Sorbitrate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 346261 | isosorbide dinitrate 5 MG Chewable Tablet [Sorbitrate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346263 | urofollitropin 150 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346265 | metroNIDAZOLE 7.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346265 | metroNIDAZOLE 7.5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 346266 | mupirocin 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346270 | penicillin G 1000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346271 | piperacillin 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346273 | prednicarbate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346274 | stannous fluoride 0.011 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346279 | shark liver oil 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346281 | streptokinase 300000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346282 | streptokinase 50000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346283 | streptokinase 150000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346284 | Oral Foam | Dose Form (DF) | YES | |
RxCUI: 346285 | Topical Foam | Dose Form (DF) | YES | |
RxCUI: 346286 | Topical Gel | Dose Form (DF) | YES | |
RxCUI: 346287 | Urethral Gel | Dose Form (DF) | NO | |
RxCUI: 346288 | Oral Ointment | Dose Form (DF) | YES | |
RxCUI: 346289 | Oral Powder | Dose Form (DF) | YES | |
RxCUI: 346290 | Nasal Suspension | Dose Form (DF) | NO | |
RxCUI: 346291 | sulfacetamide sodium 0.1 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346293 | tazarotene 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346296 | urea 0.1 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346297 | urofollitropin 300 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346298 | salicylic acid 2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 346298 | salicylic acid 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 346298 | salicylic acid 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 346299 | liothyronine 0.0625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346300 | triamcinolone 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346301 | Calderol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 346308 | thiopental 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346310 | aspirin 8.46 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346314 | aspirin 5.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346321 | acetaminophen 4.11 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 34633 | propamidine | Full form of descriptor (FN) | NO | |
RxCUI: 34633 | propamidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 34633 | propamidine | Designated preferred name (PT) | NO | |
RxCUI: 34633 | propamidine | Full form of descriptor (FN) | NO | |
RxCUI: 34633 | propamidine | Designated preferred name (PT) | NO | |
RxCUI: 346333 | Hb Hopkins-I | British preferred term (PTGB) | NO | |
RxCUI: 346333 | Hb Hopkins-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346333 | Hb Hopkins-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346333 | Hb Hopkins-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346333 | Hb Hopkins-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346333 | Hb Hopkins-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346333 | Hb Hopkins-I | Designated preferred name (PT) | NO | |
RxCUI: 346333 | Hb Hopkins-I | Full form of descriptor (FN) | NO | |
RxCUI: 346335 | methotrexate 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346336 | trimethaphan 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346339 | clenbuterol 0.002 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 34634 | Propamidine isetionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 34634 | Propamidine isetionate | Designated preferred name (PT) | NO | |
RxCUI: 34634 | Propamidine isetionate | Full form of descriptor (FN) | NO | |
RxCUI: 34634 | Propamidine isetionate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346340 | clenbuterol 0.005 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346341 | Rho(D) immune globulin 0.096 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346359 | sodium fluoride 0.004 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346360 | albuterol 1.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346361 | ketotifen 0.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346362 | theophylline 230 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346363 | albuterol 0.15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346364 | ketotifen 0.08 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346365 | gabapentin 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346366 | Niaspan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 346368 | suramin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346369 | phloroglucinol 10.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346380 | clavulanate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346420 | floxacillin 167 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346421 | floxacillin 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346424 | Emtexate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 346427 | floxacillin 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346428 | piperacillin 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 34644 | propentofylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 346447 | aclarubicin 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346448 | molgramostim 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346460 | colistin 500000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346471 | interferon beta-1b 8000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346473 | immunoglobulin G, human 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 346475 | follitropin beta 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346485 | teicoplanin 66.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 346489 | vancomycin 87 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 34649 | propicillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 346494 | somatropin 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 346494 | somatropin 5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 346501 | nystatin 500000 UNT Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346504 | cephradine 250 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346505 | chlorothiazide 500 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346508 | indomethacin 1 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 346508 | indomethacin 1 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 346508 | indomethacin 1 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 346508 | indomethacin 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 346508 | indomethacin 1 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 346508 | indomethacin 1 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 346558 | clotrimazole 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346573 | lipase 4,500 UNT / amylase 20,000 UNT / protease 25,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346573 | lipase 4,500 UNT / amylase 20,000 UNT / protease 25,000 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346573 | lipase 4,500 UNT / amylase 20,000 UNT / protease 25,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346573 | lipase 4,500 UNT / amylase 20,000 UNT / protease 25,000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346574 | theophylline 200 MG Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 346574 | theophylline 200 MG Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 346574 | theophylline 200 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 346574 | theophylline 200 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 346574 | theophylline 200 MG Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 346574 | theophylline 200 MG Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 34658 | Propanoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 34658 | Propanoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 34658 | Propanoic acid | Designated preferred name (PT) | YES | |
RxCUI: 34658 | Propanoic acid | Full form of descriptor (FN) | YES | |
RxCUI: 346605 | ethanol 0.05 ML/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 34661 | Propionyl-coenzyme A carboxylase | Designated preferred name (PT) | NO | |
RxCUI: 34661 | Propionyl-coenzyme A carboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 34661 | Propionyl-coenzyme A carboxylase | Full form of descriptor (FN) | NO | |
RxCUI: 346618 | clarithromycin 250 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346619 | ascorbic acid 1 GM/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346619 | ascorbic acid 1 GM/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346619 | ascorbic acid 1 GM/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346619 | ascorbic acid 1 GM/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346619 | ascorbic acid 1 GM/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346650 | erythromycin 500 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346712 | methylTESTOSTERone 10 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346712 | methylTESTOSTERone 10 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 346713 | thioridazine 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346714 | thioridazine 100 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346715 | pindolol 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346733 | guaiFENesin 183 MG / theophylline 305 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346733 | guaiFENesin 183 MG / theophylline 305 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346733 | guaiFENesin 183 MG / theophylline 305 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 346733 | guaiFENesin 183 MG / theophylline 305 MG Oral Capsule | Designated preferred name (PT) | NO | |
RxCUI: 346733 | guaiFENesin 183 MG / theophylline 305 MG Oral Capsule | Full form of descriptor (FN) | NO | |
RxCUI: 346736 | Lysine 3650 MG / K+ bicarbonate 2000 MG / K+ Chloride 2240 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346736 | Lysine 3650 MG / K+ bicarbonate 2000 MG / K+ Chloride 2240 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346736 | Lysine 3650 MG / K+ bicarbonate 2000 MG / K+ Chloride 2240 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346737 | Lysine 0.91 MG / Pot bicarbonate 500 MG / Pot Chloride 1500 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346737 | Lysine 0.91 MG / Pot bicarbonate 500 MG / Pot Chloride 1500 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346737 | Lysine 0.91 MG / Pot bicarbonate 500 MG / Pot Chloride 1500 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346738 | Lysine 910 MG / K+ bicarbonate 500 MG / K+ Chloride 1500 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346738 | Lysine 910 MG / K+ bicarbonate 500 MG / K+ Chloride 1500 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346738 | Lysine 910 MG / K+ bicarbonate 500 MG / K+ Chloride 1500 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346739 | ergocalciferol 500,000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346739 | ergocalciferol 500,000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346739 | ergocalciferol 500,000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346739 | ergocalciferol 500,000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346739 | ergocalciferol 500,000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346741 | betamethasone 1.2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346760 | betamethasone 0.012 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346763 | cellulose sodium phosphate 1000 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346765 | antipyrine 5.4 % / benzocaine 1.44 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346765 | antipyrine 5.4 % / benzocaine 1.44 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346765 | antipyrine 5.4 % / benzocaine 1.44 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346773 | SK 150000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346773 | SK 150000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346777 | INH 100 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346777 | INH 100 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346778 | INH 300 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346778 | INH 300 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346805 | dextrose 5 % / ethanol 10 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346805 | dextrose 5 % / ethanol 10 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346806 | ethanol 0.05 ML/ML / glucose 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346887 | PHENobarbital 16.2 MG / atropine 0.0195 MG / hyoscyamine 0.104 MG / scopolamine 0.0065 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346887 | PHENobarbital 16.2 MG / atropine 0.0195 MG / hyoscyamine 0.104 MG / scopolamine 0.0065 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 346887 | PHENobarbital 16.2 MG / atropine 0.0195 MG / hyoscyamine 0.104 MG / scopolamine 0.0065 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346894 | cystine 3.5 MG/ML / inositol 8.3 MG/ML / racemethionine 8.3 MG/ML / sodium propionate 5 MG/ML / urea 83.3 MG/ML Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346904 | K+ Chloride 97.2 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346904 | K+ Chloride 97.2 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346904 | K+ Chloride 97.2 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346905 | atropine 0.03 MG / hyoscyamine 0.03 MG / methenamine 40.8 MG / phenyl salicylate 18.1 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346910 | sodium salicylate 324 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346911 | sodium salicylate 648 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 34693 | Propylene glycol | Full form of descriptor (FN) | YES | |
RxCUI: 34693 | Propylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 34693 | Propylene glycol | Designated preferred name (PT) | YES | |
RxCUI: 34693 | Propylene glycol | Full form of descriptor (FN) | YES | |
RxCUI: 34693 | Propylene glycol | Designated preferred name (PT) | YES | |
RxCUI: 346937 | theophylline 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346951 | salicylic acid 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346952 | salicylic acid 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346959 | dihydro-alpha-ergocryptine 0.222 MG / dihydro-beta-ergocryptine 0.111 MG / dihydroergocornine 0.333 MG / dihydroergocristine 0.333 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346963 | salicylic acid 750 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346966 | brompheniramine maleate 0.8 MG/mL / pseudoephedrine HCl 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 346966 | brompheniramine maleate 0.8 MG/mL / pseudoephedrine HCl 6 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346968 | Product containing precisely testosterone 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 346968 | Product containing precisely testosterone 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 346968 | Product containing precisely testosterone 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 346975 | sodium fluoride 2.21 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 346975 | sodium fluoride 2.21 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 346975 | sodium fluoride 2.21 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 346975 | sodium fluoride 2.21 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |